Chicago-based private equity firm Shore Capital Partners announced the sale of Argentum Medical to BioDerm, a portfolio company of Denver-based private equity firm Mountaingate Capital.
The transaction closed on January 31, 2023. Moelis & Company served as financial advisor to Argentum and Winston & Strawn LLP served as legal advisor to Shore and Argentum. Terms of the deal were not disclosed.
Based in Geneva, Illinois, Argentum is a provider of infection prevention solutions for the management of wounds. Notably, it manufactures Silverlon, a silver-plated nylon dressing with unique antimicrobial properties. Argentum’s product lines include surgical, burn care, wound care, negative wound pressure therapy, dressings for IVs and catheters and antimicrobial skin and wound cleansers.
BioDerm is one of the nation’s leading manufacturers of proprietary hydrocolloid products for urinary management, securement and skin protection. Based in Largo, Florida, BioDerm’s products are sold in more than 20 countries worldwide.
According to data captured in the LevinPro HC database, this acquisition represents the 18thMedical Devices deal of 2023. By comparison, there were 13 Medical Devices transactions announced between January 1, 2022, and February 7, 2022.
